Access Official Technical PDF

Share Summary:LinkedInEmail

Silicon technology in healthcare is attracting interest because it may bring some of the semiconductor industry’s strengths—miniaturization, precision and repeatable manufacturing—to biological research and medical devices. The opportunity is broader than making smaller components. It includes creating tools that can interact with cells, measure biological signals and support research into how the human body works.

Work described by imec’s life sciences and imaging team illustrates several directions for this effort: growing cells on chips, using sensor-equipped chips to study the brain, developing interfaces for prosthetics, and combining sensors with optical technologies and microfluidics. These applications are still distinct challenges, but they share a need to connect engineered systems with complex biological environments.

Where silicon technology in healthcare could contribute

Semiconductor processes can produce compact structures with precisely arranged components. In healthcare research, that capability can be applied to devices designed to measure or influence biological activity. The goal is not simply to transfer conventional chip design into medicine. Devices must also work with cells and bodily systems, which introduce requirements that are different from those of standard computing applications.

One example is a chip that supports cell growth and analysis. Researchers can use such systems to examine how cells behave and interact. In neural research, chip-based approaches may help investigate communication between neurons. Other concepts include chips with small needles for brain analysis and interfaces that could allow prosthetics to support both movement and a sense of feeling.

Sensors, optical solutions and microfluidics are also part of this developing toolkit. Microfluidics enables the handling of small volumes of fluid within a device, while sensors and optical components can help capture information from the system being studied. Their combination can support more integrated experimental platforms, though each application requires careful design around its biological purpose.

Organ-on-chip platforms and drug research

An organ-on-chip platform can bring cells and fluid-handling structures together to create an environment that mimics aspects of human physiology. In the platform described by imec, a high-density multi-electrode array chip is combined with a microfluidic well plate. Cells are cultured in the wells, while electrodes measure electrical activity.

The system was designed to support parallel testing and multiparametric analysis. Its electrodes can detect intracellular action potentials as well as traditional extracellular signals. This type of measurement can provide researchers with different views of cellular activity within the same platform.

For pharmaceutical research, platforms that allow multiple tests in parallel may support the drug development process by providing biological measurements in a controlled device. The important point is that an organ-on-chip is not just a smaller laboratory vessel. It integrates cell culture, fluid handling and electrical measurement, making the interaction between these elements central to the platform’s design.

Manufacturing is part of the healthcare challenge

A promising device has limited reach if it cannot be manufactured reliably and at a scale appropriate to its intended use. This is a familiar concern in semiconductor production, where a manufacturing platform helps move technologies from development toward wider availability. Healthcare devices that depend on sophisticated silicon components face a similar need to connect research and production.

Scale is particularly relevant when the intended use extends across large populations. The engineering challenge is therefore not only to demonstrate that a chip can perform a measurement. Developers must also consider how the device and its manufacturing process can support consistent production and deployment.

However, biological systems are not interchangeable with conventional semiconductor materials. As imec’s presentation emphasized, the human body is largely composed of water, a factor that cannot be ignored when designing healthcare solutions. Chip materials, fluid pathways and sensing methods must be considered in relation to the environment in which the device is expected to operate.

From device concepts to practical interfaces

Research into electrical interfaces with the body may extend beyond neurological applications. Areas discussed include devices aimed at influencing signals associated with the heart, rheumatoid arthritis, gastrointestinal disorders and diabetes. These examples reflect a broader effort to understand the body as an electrical system and explore whether engineered devices can interact with it.

That direction should not be mistaken for a near-term replacement of medicines with chips. The role of silicon will depend on continued research into biological systems, device design and the practical requirements of each application. The technologies described are examples of possible approaches, not evidence that every condition can be addressed through an electronic interface.

What engineers and manufacturers should take away

For automation and manufacturing professionals, the emerging intersection of semiconductors and healthcare highlights the importance of designing for both technical performance and manufacturability. Relevant considerations include:

  • Integration: Bringing sensing, fluid handling and cell-compatible structures together requires coordination across different engineering disciplines.
  • Measurement: Platforms may need to capture multiple types of biological signals, such as intracellular and extracellular electrical activity.
  • Production: A route from research prototypes to broader use depends on manufacturing approaches capable of supporting the intended scale.
  • Application fit: Device designs must account for the biological environment and the specific question or function they are intended to address.

Silicon technology in healthcare is not a single product category, but a set of developing approaches that connect semiconductor engineering with biological research and medical applications. Cell-analysis chips, organ-on-chip platforms, sensors and neural interfaces show how this connection could take shape. Their practical impact will depend on understanding biological constraints as carefully as engineering ones—and on building manufacturing platforms that can turn promising devices into usable technologies.

Access Official Technical PDF

About The Author